SELECT DISTINCT 商品名称 FROM [dbo].[CCDD] WHERE 商品编码 = {content.Title}, -->"/> SELECT DISTINCT 规格型号 FROM [dbo].[CCDD] WHERE 商品编码 = {content.Title}, -->"/>

30-30 Pharmaceuticals

LOCATION:HOME - Chemical Industry - 30-30 Pharmaceuticals

30062000

Product Description

+Product Description: Blood-grouping reagents

+Product Chinese Description: 血型试剂

Basic Information
HS Code
30062000
Product Description
Blood-grouping reagents
Product Chinese Description
血型试剂
Declaration Elements
First Unit
Second Unit
Ordinary Tax Rate
Preferential Tax Rate
Export Tax Rate
Vat Rate
Tax Rebate Rate
Consumption Tax Rate
Customs Supervision Conditions
Inspection and Quarantine
Export Analysis
  • Report Number: No.EX30062000
  • Report Title: Export Blood-grouping reagents Trade Data Report
  • Report Format: Digital Version
  • Delivery Method: Send Online
  • Order Hotline: 65-85447467
 

Export Blood-grouping reagents Trade Data Report

Time Limit:Custom Time Period
----Data Source: Big Trade Data DaaS BI System (BTDaaS)

Part Ⅰ Export Blood-grouping reagents Statistics by Country
 1.1 Statistics by Country
 1.2 Export Quantity from China to All Other Countries by Month
 1.3 Export Value from China to All Other Countries by Month

Part Ⅱ Export Blood-grouping reagents Statistics by Province
 2.1 Statistics by Province
 2.2 Export Quantity of Every Province by Month
 2.3 Export Value of Every Province by Month
 2.4 Exports from Every Province to Every Country
   2.4.1 Exports Quantity from Every Province to Every Country
   2.4.2 Exports Value from Every Province to Every Country

Part Ⅲ Export Blood-grouping reagents Statistics by Trade Method, Shipment and Plant Location
 3.1 Statistics by Trade Method

Part Export Blood-grouping reagents Price of Export and Product Grade
 4.1 Average Price Monthly Distribution
 4.2 Average Price Country Distribution
 4.3 Average Price Province/City Distribution"
 4.4 Average Price Distribution by Trade Mode

 

Statement:This report is for reference and research purposes of industry-related companies only. Any company is strictly prohibited from using it for commercial purposes or speculation. Without our written consent, no company shall provide all or part of the content of this report to other organizations or individuals, and it is limited to internal research within the company. Without our written authorization, no newspaper, magazine, website, television, or any other media is allowed to copy, broadcast, quote, or publish any text or data in this report. Any violation of this policy will result in legal action to protect our rights, and any disputes arising from this violation shall be borne by the company itself.

Import Analysis
  • Report Number: No.EX30062000
  • Report Title: Import Blood-grouping reagents Trade Data Report
  • Report Format: Digital Version
  • Delivery Method: Send Online
  • Order Hotline: 65-85447467
 

Import Blood-grouping reagents Trade Data Report

Time Limit:Custom Time Period
----Data Source: Big Trade Data DaaS BI System (BTDaaS)

Part Ⅰ Import Blood-grouping reagents Statistics by Country
 1.1 Statistics by Country
 1.2 Import Quantity from China to All Other Countries by Month
 1.3 Import Value from China to All Other Countries by Month

Part Ⅱ Import Blood-grouping reagents Statistics by Province
 2.1 Statistics by Province
 2.2 Import Quantity of Every Province by Month
 2.3 Import Value of Every Province by Month
 2.4 Imports from Every Province to Every Country
   2.4.1 Imports Quantity from Every Province to Every Country
   2.4.2 Imports Value from Every Province to Every Country

Part Ⅲ Import Blood-grouping reagents Statistics by Trade Method, Shipment and Plant Location
 3.1 Statistics by Trade Method

Part Import Blood-grouping reagents Price of Import and Product Grade
 4.1 Average Price Monthly Distribution
 4.2 Average Price Country Distribution
 4.3 Average Price Province/City Distribution
 4.4 Average Price Distribution by Trade Mode

 

Statement:This report is for reference and research purposes of industry-related companies only. Any company is strictly prohibited from using it for commercial purposes or speculation. Without our written consent, no company shall provide all or part of the content of this report to other organizations or individuals, and it is limited to internal research within the company. Without our written authorization, no newspaper, magazine, website, television, or any other media is allowed to copy, broadcast, quote, or publish any text or data in this report. Any violation of this policy will result in legal action to protect our rights, and any disputes arising from this violation shall be borne by the company itself.